Gentry Private Wealth’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Gentry Private Wealth’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$900K	Sell	4,483 -180	-4%	-$37.2K	0.54%	27
2025 Q4	$963K	Hold	4,663	–	–	0.61%	24
2025 Q3	$836K	Hold	4,663	–	–	0.58%	25
2025 Q2	$752K	Hold	4,663	–	–	0.58%	25
2025 Q1	$793K	Buy	+4,663	New	+$810K	0.65%	22
2024 Q4	–	Sell	-4,707	Closed	-$809K	–	49
2024 Q3	$809K	Sell	4,707 -450	-9%	-$74.5K	0.66%	25
2024 Q2	$794K	Buy	+5,157	New	+$774K	0.7%	25

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Gentry Private Wealth's FBT Position: Q1 2026 in Review

Gentry Private Wealth reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3.9% in Q1 2026, selling an estimated $37.2K and leaving 4,483 shares worth $900K. The position accounts for 0.54% of the portfolio, ranked #27.

Gentry Private Wealth first reported a position in FBT in Q2 2024 and has held it in 7 quarters since. The position peaked at $963K in Q4 2025. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Gentry Private Wealth held 4,483 shares of First Trust NYSE Arca Biotechnology Index Fund worth $900K as of Q1 2026.
Gentry Private Wealth sold 180 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $37.2K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.54% of Gentry Private Wealth's portfolio in Q1 2026, its #27 holding.
Gentry Private Wealth first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 7 quarters since.
Gentry Private Wealth's First Trust NYSE Arca Biotechnology Index Fund position peaked at $963K in Q4 2025.
308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Gentry Private Wealth's 13F filing for Q1 2026, filed 5 May 2026.